MedTrace Logo

A Worldwide Score for Hepatocellular Cancer and Liver Transplantation

NCT03595345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3100

Last updated 2018-10-29

No results posted yet for this study

Summary

The present study has been developed with multiple aims: 1) to refine available models for liver transplantation which would be able to cover the fate of HCC candidates from an ITT point of view; 2) to develop such an approach on cohorts coming from both Eastern and Western countries; 3) to maintain simplicity of use; 4) to provide individual prognostication taking into account different causes of death, through a competing-risk model; 5) to provide an external validation on cohorts coming from both Eastern and Western countries. All these aims converge at providing a comprehensive and useful assessment suitable for both candidates selection and allocation priority.

Conditions

Interventions

PROCEDURE

Liver transplantation

Liver transplantation

Sponsors & Collaborators

  • European Hepatocellular Cancer Liver Transplant Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-15
Primary Completion
2018-10-15
Completion
2018-10-15

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03595345 on ClinicalTrials.gov